Drugs / Beriplex P/N
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01656330 | Jul → Aug 2012 | — | Janssen Research & Development, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beriplex P/N | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01656330 ↗ |
| Route | Intravenous | “Beriplex P/N 50 IU/kg administered by intravenous (IV) injection” NCT01656330 ↗ |